Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Post by Stuatoron May 19, 2016 2:13pm
206 Views
Post# 24889348

I said this 3 months ago too

I said this 3 months ago tooThere isn't 80 cents worth of cash in this company/share.  There is 48 cents cash/share ($16,317,167 CAD).  Under these market conditions (poor), I could easily see this test the 50 cent mark; especially considering the market's negativity towards reverse splts.  Also, their recievables went down 12M, even though the loan book grew 20M.  Meaning the amount drawn by customers decreased, while the amount available to said customers increased.  Not a good sign... as this negatively affects profitability.  Also, concerning risk, they haven't, to date, factored for any potential losses on the loan book.  
With all this said, I believe this stock should be trading at a discount to cash, as the metrics of the business have diminished since the last quarter, the negativity towards a reverse split is very real and likely, and they don't have enough past data to properly discount their loan book. 

My guess this trades down to 40 cents or more now to get a discount to cash of about 75%..
Bullboard Posts